Lannett Co., Inc.
LCI
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.38M
Close$
Share Statistics
| Market cap | $7.38 Million |
|---|---|
| Enterprise Value | $600.47 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-22.96 |
| Beta | 0.95 |
| Outstanding Shares | 10,311,428 |
Return
| Return on Equity | 62.85% |
|---|---|
| Return on Assets | -77.43% |
| Return on Invested Capital | 14.20% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | -0.02 |
| Price to Sales | 0.02 |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | 1.93 |
| Enterprise Value to EBIT | -10.62 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.07 |
| Debt to Equity | -1.55 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lannett Co., Inc.
564 employees
CEO: Timothy Crew Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.